VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 2561 · 115th Congress

Stopping Suspicious Orders of Opioids Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

1 cosponsor · 1 R

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill amends the Controlled Substances Act (CSA) to modify enforcement authorities of the Drug Enforcement Administration (DEA).

What it does: CRS summary · Introduced in Senate · Mar 15, 2018

Stopping Suspicious Orders of Opioids Act

This bill amends the Controlled Substances Act (CSA) to modify enforcement authorities of the Drug Enforcement Administration (DEA).

Currently, the DEA may deny, revoke, or suspend a registration for a CSA violation. It must first issue an order to show cause which, among other things, notifies an applicant or registrant of the opportunity to submit a corrective plan (CAP). This bill specifies that if the DEA does not approve a CAP, or if an applicant or registrant fails to implement a DEA-approved CAP within 30 days, then the DEA must: (1) reinstate administrative proceedings to deny, revoke, or suspend the registration; and (2) immediately suspend the registration, in the case of a registrant.

Additionally, the bill modifies the standard of review to immediately suspend a registration. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety. This bill lowers the standard for determining imminent danger to the public health and safety—from substantial likelihood of an immediate threat to likelihood of a threat.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Stopping Suspicious Orders of Opioids Act

Latest action (Mar 15, 2018): Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S1766-1767)

Policy area: Crime and Law Enforcement · Origin: Senate · Introduced: Mar 15, 2018

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.